Talus Bio

Seed
talus.bio AI & Machine Learning Seattle, United States 16 employees
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Sep 21, 2026
Investors 11 Backers
Decision Makers 6 Verified

About Talus Bio

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Seed
Global Headquarters Seattle, United States
Team Size 16 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website talus.bio
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @talusbio (674 followers) Created on May 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

  2. Capital Raise

    Seed announced

    fundraisingfox.com

  3. Milestone

    X account created (@talusbio)

    674 followers

Investors & Backers

11
BoxOne Ventures
Farvatn Venture
FundersClub
NCATS
NFX
Plug and Play
Rolling Bay Ventures
Two Bear Capital
WRF Capital
Y Combinator
YC Continuity

Funding History

3 Rounds
Seed · Sep 21, 2026
Undisclosed
Seed · Jun 7, 2022
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

4

Alex Federation

Co-Founder, CEO

Work email & phone locked Unlock →

Christopher Joyce

Vice President of Business Development

Work email & phone locked Unlock →

Lindsay Pino

Co-Founder and CTO

Work email & phone locked Unlock →

Michelle Briscoe

COO and CFO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts